132 related articles for article (PubMed ID: 29228699)
1. Iron depletion is a novel therapeutic strategy to target cancer stem cells.
Ninomiya T; Ohara T; Noma K; Katsura Y; Katsube R; Kashima H; Kato T; Tomono Y; Tazawa H; Kagawa S; Shirakawa Y; Kimura F; Chen L; Kasai T; Seno M; Matsukawa A; Fujiwara T
Oncotarget; 2017 Nov; 8(58):98405-98416. PubMed ID: 29228699
[TBL] [Abstract][Full Text] [Related]
2. A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.
Katsura Y; Ohara T; Noma K; Ninomiya T; Kashima H; Kato T; Sato H; Komoto S; Narusaka T; Tomono Y; Xing B; Chen Y; Tazawa H; Kagawa S; Shirakawa Y; Kasai T; Seno M; Matsukawa A; Fujiwara T
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717462
[TBL] [Abstract][Full Text] [Related]
3. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
Narusaka T; Ohara T; Noma K; Nishiwaki N; Katsura Y; Kato T; Sato H; Tomono Y; Kikuchi S; Tazawa H; Shirakawa Y; Matsukawa A; Fujiwara T
Int J Cancer; 2021 Jul; 149(2):347-357. PubMed ID: 33662150
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Iron Chelators on the Biology of Cancer Stem Cells.
Szymonik J; Wala K; Górnicki T; Saczko J; Pencakowski B; Kulbacka J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008527
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells maintain a hierarchy of differentiation by creating their niche.
Matsuda S; Yan T; Mizutani A; Sota T; Hiramoto Y; Prieto-Vila M; Chen L; Satoh A; Kudoh T; Kasai T; Murakami H; Fu L; Salomon DS; Seno M
Int J Cancer; 2014 Jul; 135(1):27-36. PubMed ID: 24323788
[TBL] [Abstract][Full Text] [Related]
6. iPSC-derived cancer stem cells provide a model of tumor vasculature.
Prieto-Vila M; Yan T; Calle AS; Nair N; Hurley L; Kasai T; Kakuta H; Masuda J; Murakami H; Mizutani A; Seno M
Am J Cancer Res; 2016; 6(9):1906-1921. PubMed ID: 27725898
[TBL] [Abstract][Full Text] [Related]
7. Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma.
Paterson C; Kilmister EJ; Brasch HD; Bockett N; Patel J; Paterson E; Purdie G; Galvin S; Davis PF; Itinteang T; Tan ST
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685477
[TBL] [Abstract][Full Text] [Related]
8. A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
Chen Y; Ohara T; Xing B; Qi J; Noma K; Matsukawa A
Acta Med Okayama; 2020 Feb; 74(1):1-6. PubMed ID: 32099242
[TBL] [Abstract][Full Text] [Related]
9. Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium.
Xu N; Li X; Watanabe M; Ueki H; Hu H; Li N; Araki M; Wada K; Xu A; Liu C; Nasu Y; Huang P
Am J Cancer Res; 2018; 8(8):1624-1632. PubMed ID: 30210930
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting
Zhang Q; Yang Z; Shan J; Liu L; Liu C; Shen J; Chen X; Xu Y; Chen J; Ma Q; Yang L; Qian C
Oncotarget; 2017 Dec; 8(66):110187-110200. PubMed ID: 29299140
[TBL] [Abstract][Full Text] [Related]
11. Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma.
Matsuoka J; Yashiro M; Sakurai K; Kubo N; Tanaka H; Muguruma K; Sawada T; Ohira M; Hirakawa K
J Surg Res; 2012 May; 174(1):130-5. PubMed ID: 21227461
[TBL] [Abstract][Full Text] [Related]
12. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
13. Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.
Walter K; Rodriguez-Aznar E; Ferreira MSV; Frappart PO; Dittrich T; Tiwary K; Meessen S; Lerma L; Daiss N; Schulte LA; Najafova Z; Arnold F; Usachov V; Azoitei N; Erkan M; Lechel A; Brümmendorf TH; Seufferlein T; Kleger A; Tabarés E; Günes C; Johnsen SA; Beier F; Sainz B; Hermann PC
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201898
[TBL] [Abstract][Full Text] [Related]
14. The potential of deferasirox as a novel therapeutic modality in gastric cancer.
Choi JH; Kim JS; Won YW; Uhm J; Park BB; Lee YY
World J Surg Oncol; 2016 Mar; 14():77. PubMed ID: 26965928
[TBL] [Abstract][Full Text] [Related]
15. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell markers expression in cancers.
Schoenhals M; Kassambara A; De Vos J; Hose D; Moreaux J; Klein B
Biochem Biophys Res Commun; 2009 May; 383(2):157-62. PubMed ID: 19268426
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
18. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
19. Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment.
Oo AKK; Calle AS; Nair N; Mahmud H; Vaidyanath A; Yamauchi J; Khayrani AC; Du J; Alam MJ; Seno A; Mizutani A; Murakami H; Iwasaki Y; Chen L; Kasai T; Seno M
Transl Oncol; 2018 Jun; 11(3):653-663. PubMed ID: 29621663
[TBL] [Abstract][Full Text] [Related]
20. Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.
Kim MJ; Lee YS; Han GY; Lee HN; Ahn C; Kim CW
Biosci Biotechnol Biochem; 2015; 79(9):1438-46. PubMed ID: 25964982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]